Antitrust MDL-2724 • PAE

Generic Pharmaceuticals Pricing Antitrust

IN RE: Generic Pharmaceuticals Pricing Antitrust Litigation

142
Pending Actions
215
Total Actions Filed
34%
Resolution Rate
Active
Status
Updated 2026-05-01

Overview

The Generic Pharmaceuticals Pricing Antitrust is a federal multidistrict litigation consolidated in the PAE before Cynthia M. Rufe (Sr. District Judge). This MDL involves claims related to antitrust issues.

As of 2026-05-01, there are 142 pending actions out of 215 total actions filed, representing a 34% resolution rate.

Who May Qualify

Eligibility for this MDL typically depends on factors such as:

  • Documented exposure to or use of the product/device in question
  • Medical diagnosis of related injuries or conditions
  • Claim filed within the applicable statute of limitations

Key Information

Assigned Judge

Cynthia M. Rufe (Sr. District Judge)

District Court

PAE

MDL Number

MDL-2724

Category

Antitrust

Attorney Advertising. The information on this page is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is formed by reading this content. Results in MDL cases vary widely; past results do not guarantee future outcomes. If you believe you have a legal claim, consult a licensed attorney in your jurisdiction.